$88.7 Million is the total value of APIS CAPITAL ADVISORS, LLC's 29 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 33.3% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
DAR | Sell | DARLING INGREDIENTS INC | $5,502,000 | -43.0% | 92,000 | -23.3% | 6.20% | -46.9% |
OEC | Sell | ORION ENGINEERED CARBONS S A | $3,961,000 | -4.6% | 255,077 | -1.9% | 4.46% | -11.2% |
MGY | Sell | MAGNOLIA OIL & GAS CORPcl a | $2,981,000 | -21.2% | 142,000 | -11.2% | 3.36% | -26.7% |
ARCH | Sell | ARCH RESOURCES INCcl a | $1,717,000 | -21.9% | 12,000 | -25.0% | 1.94% | -27.3% |
GRVY | Sell | GRAVITY CO LTDsponsored ads ne | $1,223,000 | -22.1% | 24,000 | -22.6% | 1.38% | -27.4% |
IESC | Sell | IES HLDGS INC | $1,146,000 | -63.5% | 38,000 | -51.3% | 1.29% | -66.0% |
VICR | Sell | VICOR CORP | $1,095,000 | -35.3% | 20,000 | -16.7% | 1.23% | -39.8% |
LQDA | Sell | LIQUIDIA CORPORATION | $218,000 | -56.7% | 50,000 | -28.6% | 0.25% | -59.6% |
INSM | Exit | INSMED INC | $0 | – | -22,000 | -100.0% | -0.63% | – |
MYOV | Exit | MYOVANT SCIENCES LTD | $0 | – | -40,000 | -100.0% | -0.64% | – |
BTAI | Exit | BIOXCEL THERAPEUTICS INC | $0 | – | -40,000 | -100.0% | -1.01% | – |
MVBF | Exit | MVB FINL CORP | $0 | – | -84,000 | -100.0% | -4.22% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-08-12
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
SILICON MOTION TECHNOLOGY CO | 18 | Q2 2023 | 13.0% |
INTELLIGENT SYS CORP NEW | 15 | Q3 2023 | 22.4% |
GRAVITY CO LTD | 14 | Q3 2023 | 6.6% |
ORION S.A. | 12 | Q3 2023 | 10.3% |
VICOR CORP | 12 | Q3 2022 | 6.5% |
CYBEROPTICS CORP | 11 | Q2 2022 | 5.2% |
XPEL INC | 11 | Q3 2023 | 3.2% |
SILICOM LTD | 10 | Q3 2023 | 14.1% |
GOLAR LNG LTD BERMUDA | 10 | Q3 2023 | 11.7% |
GARRETT MOTION INC | 10 | Q3 2023 | 3.5% |
View APIS CAPITAL ADVISORS, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
BIOSPECIFICS TECHNOLOGIES CORP | July 30, 2010 | 306,363 | 4.9% |
KHD HUMBOLDT WEDAG INTERNATIONAL LTD. | February 17, 2009 | 291,000 | 1.0% |
View APIS CAPITAL ADVISORS, LLC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-05-15 |
13F-HR | 2024-02-14 |
13F-HR | 2023-11-13 |
13F-HR | 2023-08-11 |
13F-HR | 2023-05-12 |
13F-HR | 2023-02-14 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-12 |
13F-HR | 2022-05-13 |
13F-HR | 2022-02-14 |
View APIS CAPITAL ADVISORS, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.